慢性抑郁症患者的药物和非药物等待名单期间的症状变化
Andreas Høstmælingen1, Helene Amundsen Nissen-Lie1, Bruce Wampold2,3
1Department of Psychology, University of Oslo, Oslo, Norway.
Psychotherapy and psychosomatics
|September 14, 2023
概括
在心理治疗等候名单上的慢性抑郁患者经历了症状的减少,特别是那些不使用抗抑郁药物的患者. 这表明,治疗期望可能会在等待名单期间对结果产生积极影响.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 寻求心理治疗的患者经常面临等待名单,对症状进展的影响尚不清楚.
- 抗抑郁药物 (ADM) 对等候名单症状变化的影响尚未被探索.
研究的目的:
- 评估慢性抑郁症患者在住院心理治疗前等候名单期间的症状变化.
- 为了比较使用ADM和不使用ADM的患者之间的等待列表症状变化.
主要方法:
- 一项对313名慢性抑郁症患者进行的自然主义研究.
- 使用贝克抑郁症目录II进行症状追踪,用于评估,等待列表后,治疗后和1年的随访.
- 多层次的增长曲线分析,以检查等候名单的变化,区分ADM用户和非用户.
主要成果:
- 从评估到入院发生了显著的症状减少 (科恩d = 0.47).
- 与未服用药物的患者 (d = 0.65) 相比,ADM使用者 (d = 0.39) 的症状减轻程度较低.
结论:
- 慢性抑郁症患者在等待名单期间表现出症状改善,这可能是由于治疗期望.
- 在ADM使用者中,较低的症状改善可能与阳性并发症或精神衰弱有关.
更多相关视频
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
722
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
91
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
270
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
270
01:27Depressive Disorders: MDD and Dysthymia
154
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
154
01:28Drug Therapy
68
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
68
01:54The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
01:25Antidepressant Drugs: Overview
555
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
555
01:26Psychosis: Goals of Pharmacotherapy
165
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
165